Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Study of Anti-Inflammatory Activity of a New Non-Opioid Analgesic on the Basis of a Selective Inhibitor of TRPA1 ion Channels.

Beskhmelnitsyna EA, Pokrovskii MV, Kulikov AL, Peresypkina AA, Varavin EI.

Antiinflamm Antiallergy Agents Med Chem. 2019 Feb 8. doi: 10.2174/1871523018666190208123700. [Epub ahead of print]

PMID:
30734687
2.

Author Correction: c-MAF-dependent regulatory T cells mediate immunological tolerance to a gut pathobiont.

Xu M, Pokrovskii M, Ding Y, Yi R, Au C, Harrison OJ, Galan C, Belkaid Y, Bonneau R, Littman DR.

Nature. 2019 Feb;566(7744):E7. doi: 10.1038/s41586-019-0922-z.

PMID:
30723268
3.

Correction of Experimental Retinal Ischemia by l-Isomer of Ethylmethylhydroxypyridine Malate.

Peresypkina A, Pazhinsky A, Pokrovskii M, Beskhmelnitsyna E, Pobeda A, Korokin M.

Antioxidants (Basel). 2019 Feb 3;8(2). pii: E34. doi: 10.3390/antiox8020034.

4.

Leveraging chromatin accessibility for transcriptional regulatory network inference in T Helper 17 Cells.

Miraldi ER, Pokrovskii M, Watters A, Castro DM, De Veaux N, Hall JA, Lee JY, Ciofani M, Madar A, Carriero N, Littman DR, Bonneau R.

Genome Res. 2019 Mar;29(3):449-463. doi: 10.1101/gr.238253.118. Epub 2019 Jan 29.

5.

Dynamics of Interactions between Cerebral Networks Derived from fMRI Data and Motor Rehabilitation during Stokes.

Savelov AA, Shtark MB, Kozlova LI, Verevkin EG, Petrovskii ED, Pokrovskii MA, Rudych PD, Tsyrkin GM.

Bull Exp Biol Med. 2019 Jan;166(3):399-403. doi: 10.1007/s10517-019-04359-6. Epub 2019 Jan 9.

PMID:
30627902
6.

Dynamics of fMRI and EEG Parameters in a Stroke Patient Assessed during a Neurofeedback Course Focused on Brodmann Area 4 (M1).

Savelov AA, Shtark MB, Mel'nikov ME, Kozlova LI, Bezmaternykh DD, Verevkin EG, Petrovskii ED, Pokrovskii MA, Tsirkin GM, Rudych PD.

Bull Exp Biol Med. 2019 Jan;166(3):394-398. doi: 10.1007/s10517-019-04358-7. Epub 2019 Jan 9.

PMID:
30627901
7.

Prospects of Synchronous fMRI-EEG Recording as the Basis for Neurofeedback (Exemplified on Patient with Stroke Sequelae).

Savelov AA, Shtark MB, Mel'nikov ME, Kozlova LI, Bezmaternykh DD, Verevkin EG, Petrovskii ED, Pokrovskii MA, Tsirkin GM, Rudych PD.

Bull Exp Biol Med. 2019 Jan;166(3):390-393. doi: 10.1007/s10517-019-04357-8. Epub 2019 Jan 9.

PMID:
30627899
8.

c-MAF-dependent regulatory T cells mediate immunological tolerance to a gut pathobiont.

Xu M, Pokrovskii M, Ding Y, Yi R, Au C, Harrison OJ, Galan C, Belkaid Y, Bonneau R, Littman DR.

Nature. 2018 Feb 15;554(7692):373-377. doi: 10.1038/nature25500. Epub 2018 Feb 7. Erratum in: Nature. 2019 Feb;566(7744):E7.

9.

Study of Endothelial Protective Activity of Phenol-Derived Thrombin and Arginase-2 Inhibitors KUD-259 and KUD-974.

Pokrovskii MV, Korokin MV, Kudryavtsev KV, Pokrovskaya TG, Gudyrev OS, Gureev VV, Korokina LV, Povetkin SV.

Bull Exp Biol Med. 2017 Aug;163(4):436-438. doi: 10.1007/s10517-017-3822-y. Epub 2017 Aug 29.

PMID:
28853095
10.

Critical role of IRF1 and BATF in forming chromatin landscape during type 1 regulatory cell differentiation.

Karwacz K, Miraldi ER, Pokrovskii M, Madi A, Yosef N, Wortman I, Chen X, Watters A, Carriero N, Awasthi A, Regev A, Bonneau R, Littman D, Kuchroo VK.

Nat Immunol. 2017 Apr;18(4):412-421. doi: 10.1038/ni.3683. Epub 2017 Feb 6.

11.

Raven's Progressive Matrices in the Lexicon of Dynamic Mapping of the Brain (MRI).

Mazhirina KG, Mel'nikov ME, Pokrovskii MA, Petrovskii ED, Savelov AA, Shtark MB.

Bull Exp Biol Med. 2016 Apr;160(6):850-6. doi: 10.1007/s10517-016-3325-2. Epub 2016 May 11.

PMID:
27165076
12.

Synergetic fMRI-EEG brain mapping in alpha-rhythm voluntary control mode.

Shtark MB, Verevkin EG, Kozlova LI, Mazhirina KG, Pokrovskii MA, Petrovskii ED, Savelov AA, Starostin AS, Yarosh SV.

Bull Exp Biol Med. 2015 Mar;158(5):644-9. doi: 10.1007/s10517-015-2827-7. Epub 2015 Mar 17.

PMID:
25778652
13.

Possible role and application of fMRI in the screening of release-active drugs.

Duma SN, Rezakova MV, Mazhirina KG, Petrovskii ED, Pokrovskii MA, Dzhafarova OA, Savelov AA, Shtark MB, Epstein OI.

Bull Exp Biol Med. 2015 Feb;158(4):453-7. doi: 10.1007/s10517-015-2783-2. Epub 2015 Feb 24.

PMID:
25708324
14.

Dynamic mapping of the brain in substance-dependent individuals: functional magnetic resonance imaging.

Mel'nikov ME, Shtark MB, Korostyshevskaya AM, Sevelov AA, Petrovskii ED, Pokrovskii MA, Rezakova MV, Ganenko YA, Il'ichevskii IN, Mazhirina KG, Mezentseva MP, Kosykh EP.

Bull Exp Biol Med. 2014 Dec;158(2):260-3. doi: 10.1007/s10517-014-2736-1. Epub 2014 Nov 29.

PMID:
25432285
15.

Trace effects of game biofeedback: functional MRI study.

Mazhirina KG, Rezakova MV, Pokrovskii MA, Savelov AA, Shtark MB.

Bull Exp Biol Med. 2014 Jul;157(3):336-40. doi: 10.1007/s10517-014-2560-7. Epub 2014 Jul 29.

PMID:
25065313
16.

A small-molecule inhibitor of hepatitis C virus infectivity.

Bush CO, Pokrovskii MV, Saito R, Morganelli P, Canales E, Clarke MO, Lazerwith SE, Golde J, Reid BG, Babaoglu K, Pagratis N, Zhong W, Delaney WE 4th, Paulson MS, Beran RK.

Antimicrob Agents Chemother. 2014;58(1):386-96. doi: 10.1128/AAC.02083-13. Epub 2013 Oct 28.

17.

[Antitumor activity of dihydrobetulonic acid amides in vitro and in vivo].

Sorokina IV, Maĭnagashev IIu, Zhukova NA, Korchagina DV, Tolstikova TG, Nikolin VP, Popova NA, Pokrovskiĭ MA, Pokrovskiĭ AG, Salakhutdinov NF.

Bioorg Khim. 2013 Mar-Apr;39(2):221-9. Russian.

PMID:
23964523
18.

[Synthetic transformations of higher terpenoids. XXX. Synthesis and cytotoxic activity of betulonic acid amides with a piperidine or pyrrolidine nitroxide moiety].

Antimonova AN, Petrenko NI, Shults EE, Polienko IuF, Shakirov MM, Irtegova IG, Pokrovskiĭ MA, Sherman KM, Grigor'ev IA, Pokrovskiĭ AG, Tolstikov GA.

Bioorg Khim. 2013 Mar-Apr;39(2):206-11. Russian.

PMID:
23964521
19.

[Comparative evaluation of the osteoprotective effects of resveratrol and resveratrol/enalapril combination in the treatment of experimental osteoporosis].

Faĭtel'son AV, Koklina NIu, Gudyrev OS, Dubrovin GM, Pokrovskiĭ MV, Ivanov AV.

Eksp Klin Farmakol. 2012;75(5):35-8. Russian.

PMID:
22834128
20.

[Synthetic transformations of higher terpenoids. XXVI. 16-Acetylaminomethyllabdanoids and theirs cytotoxicity].

Kharitonov IuV, Shul'ts ÉÉ, Shakirov MM, Pokrovskiĭ MA, Pokrovskiĭ AG, Tolstikov GA.

Bioorg Khim. 2012 Jan-Feb;38(1):127-36. Russian.

PMID:
22792716
21.

[Correction of endothelial dysfunction by L-arginine under experimental pre-eclampsia conditions].

Pokrovskiĭ MV, Pokrovskaia TG, Gureev VV, Barsuk AA, Proskuriakova EV, Korokin MV, Gudyrev OS, Belous AS, Kochkarov VI, Danilenko LM, Levashova OV, Mal'tseva NV, Polianskaia OS.

Eksp Klin Farmakol. 2012;75(2):14-6. Russian.

PMID:
22550853
22.

An adaptive mutation in NS2 is essential for efficient production of infectious 1b/2a chimeric hepatitis C virus in cell culture.

Chan K, Cheng G, Beran RK, Yang H, Appleby TC, Pokrovskii MV, Mo H, Zhong W, Delaney WE 4th.

Virology. 2012 Jan 20;422(2):224-34. doi: 10.1016/j.virol.2011.10.022. Epub 2011 Nov 17.

23.

Cardiac myosin activation: a potential therapeutic approach for systolic heart failure.

Malik FI, Hartman JJ, Elias KA, Morgan BP, Rodriguez H, Brejc K, Anderson RL, Sueoka SH, Lee KH, Finer JT, Sakowicz R, Baliga R, Cox DR, Garard M, Godinez G, Kawas R, Kraynack E, Lenzi D, Lu PP, Muci A, Niu C, Qian X, Pierce DW, Pokrovskii M, Suehiro I, Sylvester S, Tochimoto T, Valdez C, Wang W, Katori T, Kass DA, Shen YT, Vatner SF, Morgans DJ.

Science. 2011 Mar 18;331(6023):1439-43. doi: 10.1126/science.1200113.

24.

Selection of clinically relevant protease inhibitor-resistant viruses using the genotype 2a hepatitis C virus infection system.

Cheng G, Chan K, Yang H, Corsa A, Pokrovskii M, Paulson M, Bahador G, Zhong W, Delaney W 4th.

Antimicrob Agents Chemother. 2011 May;55(5):2197-205. doi: 10.1128/AAC.01382-10. Epub 2011 Feb 28.

25.

Novel mutations in a tissue culture-adapted hepatitis C virus strain improve infectious-virus stability and markedly enhance infection kinetics.

Pokrovskii MV, Bush CO, Beran RK, Robinson MF, Cheng G, Tirunagari N, Fenaux M, Greenstein AE, Zhong W, Delaney WE 4th, Paulson MS.

J Virol. 2011 Apr;85(8):3978-85. doi: 10.1128/JVI.01760-10. Epub 2011 Feb 2.

26.

[Integrated assessment of endothelio- and cardioprotective activity of macrolide antibiotics in nitric oxide deficiency model].

Chernomortseva ES, Pokrovskiĭ MV, Titareva LV, Pokrovskaia TG, Gureev VV.

Eksp Klin Farmakol. 2010 Sep;73(9):20-3. Russian.

PMID:
21086648
27.

Comparative study of potential endothelioprotectors and impaza in modeled nitric oxide deficiency.

Pokrovskii MV, Kochkarov VI, Pokrovskaya TG, Artyushkova EB, Pashin EN, Danilenko LM, Korokin MV, Belous AS, Korokina LV, Malykhin VA, Zaloznykh YI, Brusnik MS, Zhavbert ES.

Bull Exp Biol Med. 2009 Sep;148(3):514-7. English, Russian.

PMID:
20396727
28.

Correction of endothelial dysfunction with impaza preparation in complex with enalapril and losartan during modeling of NO deficiency.

Belous AS, Pokrovskii MV, Pokrovskaya TG, Kochkarov VI, Artyushkova EB, Pashin EN, Zhavbert ES.

Bull Exp Biol Med. 2009 Sep;148(3):511-3. English, Russian.

PMID:
20396726
29.

[Experimental study of cardioprotective and endothelioprotective action of macrolides and azalides].

Chernomortseva ES, Pokrovskiĭ MV, Pokrovskaia TG, Artiushkova EB, Gureev VV.

Eksp Klin Farmakol. 2009 Mar-Apr;72(2):29-31. Russian.

PMID:
19441724
30.

[Pharmacological correction of experimental chronic limb ischemia].

Artiushkova EB, Pashkov DV, Pokrovskiĭ MV, Faĭtel'son AV, Gudyrev OS, Pokrovskaia TG, Pashin EN, Kochkarov VI.

Eksp Klin Farmakol. 2008 May-Jun;71(3):23-5. Russian.

PMID:
18652251
31.

[Endothelioprotective properties of L-arginine in a nitric oxide deficiency model].

Pokrovskiĭ MV, Pokrovskaia TG, Kochkarov VI, Artiushkova EB.

Eksp Klin Farmakol. 2008 Mar-Apr;71(2):29-31. Russian.

PMID:
18488903
32.

Effect of antioxidants pQ510 and resveratrol on regulatory function of the endothelium in rats with modeled arterial hypertension.

Gumanova NG, Artyushkova EB, Metel'skaya VA, Kochkarov VI, Pokrovskaya TG, Danilenko LM, Korneev MM, Pokrovskii MV, Pashin EN.

Bull Exp Biol Med. 2007 Jun;143(6):678-81. English, Russian.

PMID:
18239799
33.

[The cardiac performance recovery pattern and central hemodynamics in patients with coronary heart disease during coronary bypass surgery under extracorporeal circulation].

Naumenko KS, Naumenko SE, Kim SF, Belavin AS, Pokrovskiĭ MG, Danilenko AV, Balabanov IA, Bravve IIu.

Anesteziol Reanimatol. 2007 Sep-Oct;(5):30-4. Russian.

PMID:
18051489
34.
35.
36.

[Oxygen transport and hemodynamic reactions in ischemic heart disease patients when reserving and reinfusing massive volumes of autoblood].

Naumenko SE, Pokrovskiĭ MG, Naumenko KS, Danilenko AV, Kim SF.

Vestn Khir Im I I Grek. 2004;163(6):57-63. Russian.

PMID:
15757308
37.

[Aprotinin in the correction of the hemodynamic syndrome of systemic inflammatory response in surgeries with extracorporeal circulation].

Naumenko SE, Naumenko KS, Pokrovskiĭ MG, Kim SF.

Anesteziol Reanimatol. 2004 Jul-Aug;(4):15-9. Russian.

PMID:
15468547
38.

[Efficacy of intraoperative reservation of auto-blood in surgical treatment of ischemic heart disease using Cell-Saver].

Naumenko SE, Pokrovskiĭ MG, Belavin AS, Kim SF.

Anesteziol Reanimatol. 2004 Mar-Apr;(2):43-7. Russian.

PMID:
15206277
39.

[Blood-saving effectiveness of preoperative reservation of autoblood for surgical treatment of ischemic heart disease].

Naumenko SE, Pokrovskiĭ MG, Belavin AS, Kim SF.

Vestn Khir Im I I Grek. 2003;162(2):59-64. Russian.

PMID:
14606149
40.

Prooxidant effects of nitrofurantoin.

Novikov OO, Pokrovskii MV, Konovalenko AB.

Bull Exp Biol Med. 2002 Aug;134(2):148-50.

PMID:
12459837
41.
42.

[Prophylactic syrups for population of environmentally polluted areas].

Ivanova TN, Khlebnikov VI, Pokrovskiĭ MV, Zakharchenko GL.

Vopr Pitan. 1998;(1):31-4. Russian.

PMID:
9606865
43.

[A simple gauge of volumetric blood flow velocity].

Vovereĭdt VV, Pokrovskiĭ MV, Galenko-Iaroshevskiĭ PA.

Farmakol Toksikol. 1988 Nov-Dec;51(6):95-6. Russian.

PMID:
3234549
44.

[Diagnosis of diseases of the periodontium from data of the measurement of its passive electrical properties].

Pokrovskiĭ MM, Prokhonchukov AA.

Stomatologiia (Mosk). 1988 Jan-Feb;67(1):29-32. Russian. No abstract available.

PMID:
3163191
45.

[Complex formation of lithium hydroxybutyrate with ions of Na+, K+, Ba2+, Mg2+, and Ca2+].

Galenko-Iaroshevckiĭ PA, Budarin LI, Buikliskiĭ VD, Grebennikov VN, Pokrovskiĭ MV.

Farmakol Toksikol. 1987 Nov-Dec;50(6):51-5. Russian.

PMID:
3436425
46.

[General principles of heart rate control during burst stimulation of the vagus nerve in various animals].

Sheĭkh-Zade IuR, Kruchinin VM, Sukach LI, Pokrovskiĭ MV, Urmancheva TG.

Fiziol Zh SSSR Im I M Sechenova. 1987 Oct;73(10):1325-30. Russian.

PMID:
3501381
47.

[Cardiotropic properties of lithium oxybutyrate in an experiment and in the clinic].

Galenko-Iaroshevskiĭ PA, Pokrovskiĭ MV, Skibitskiĭ VV.

Farmakol Toksikol. 1986 Sep-Oct;49(5):63-7. Russian.

PMID:
2429864
48.

[Controlled sinus arrhythmia during burst stimulation of the vagus nerve].

Sheikh-Zade IuR, Pokrovskiĭ MV.

Biull Eksp Biol Med. 1985 Apr;99(4):393-4. Russian.

PMID:
3986360
49.

[Electrical resistance and rheographic indices of the periodontium in children].

Pokrovskiĭ MM.

Stomatologiia (Mosk). 1985 Jan-Feb;64(1):58-9. Russian. No abstract available.

PMID:
3857745
50.

[Control of cardiac rhythm by stimulation of the vagus nerve in bursts in the rat].

Pokrovskiĭ MV.

Biull Eksp Biol Med. 1984 Apr;97(4):389-90. Russian.

PMID:
6722293

Supplemental Content

Loading ...
Support Center